| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092238439 |
| P356 | DOI | 10.1186/S12957-017-1252-Y |
| P932 | PMC publication ID | 5644176 |
| P698 | PubMed publication ID | 29037198 |
| P2093 | author name string | Dapeng Li | |
| Chengcheng Xu | |||
| Jiangang Liu | |||
| Qi Gui | |||
| P2860 | cites work | Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survival | Q33831950 |
| A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER) | Q34041754 | ||
| Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer | Q36625206 | ||
| Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. | Q36710600 | ||
| Involved field radiation therapy after surgical resection of solitary brain metastases--mature results. | Q36792734 | ||
| A retrospective analysis in patients with EGFR-mutant lung adenocarcinoma: is EGFR mutation associated with a higher incidence of brain metastasis? | Q37636737 | ||
| MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment? | Q39219628 | ||
| Brain metastases. Histology, multiplicity, surgery, and survival | Q40923255 | ||
| Brain metastasis effectively treated with erlotinib following the acquisition of resistance to gefitinib: a case report | Q41846992 | ||
| Incidence of leukoencephalopathy after whole-brain radiation therapy for brain metastases | Q44967100 | ||
| Cerebrospinal fluid concentrations of gefitinib in patients with lung adenocarcinoma | Q45350153 | ||
| A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-o | Q46417062 | ||
| Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology | Q48344519 | ||
| Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation | Q48480145 | ||
| Surgical management of non-small cell lung cancer with synchronous brain metastases | Q48882785 | ||
| A randomized trial of surgery in the treatment of single metastases to the brain | Q49096659 | ||
| Time for reappraisal of extracranial treatment options? | Q59587467 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | neurosurgery | Q188449 |
| P304 | page(s) | 184 | |
| P577 | publication date | 2017-10-16 | |
| P1433 | published in | World Journal of Surgical Oncology | Q14520241 |
| P1476 | title | Prolonged survival of patients with EGFR-mutated non-small cell lung cancer with solitary brain metastases treated with surgical resection of brain and lung lesions followed by EGFR TKIs | |
| P478 | volume | 15 |
| Q102057123 | Long term follow-up of EGFR mutated NSCLC cases |
| Q96305342 | Neurological Death is Common in Patients With EGFR Mutant Non-Small Cell Lung Cancer Diagnosed With Brain Metastases |
Search more.